<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-4de7-db4d-014d-e861ea2d01a1</uuid><title>Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control</title><shortTitle>IVD_Lipid_LDL</shortTitle><emeasureid>182</emeasureid><guid>500e4792-7f94-4e34-8546-ee71c56fe463</guid><version>5.2.000</version><nqfid extension="Not Applicable" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3f77-75c9-013f-77f65cca0149"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</steward><developers><developer id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</developer></developers><description>Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease (IVD) during the measurement period, and who had a complete lipid profile performed during the measurement period and whose LDL-C was adequately controlled (&lt; 100 mg/dL).</description><copyright>Physician Performance Measure (Measures) and related data specifications were developed by the National Committee for Quality Assurance (NCQA). &#xD;
&#xD;
The Measures are copyrighted but can be reproduced and distributed, without modification, for noncommercial purposes (eg, use by healthcare providers in connection with their practices). Commercial use is defined as the sale, licensing, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial use of the Measures requires a license agreement between the user and NCQA. NCQA is not responsible for any use of the Measures. &#xD;
&#xD;
(C) 2008-2015 National Committee for Quality Assurance. All Rights Reserved. &#xD;
&#xD;
Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. NCQA disclaims all liability for use or accuracy of any CPT or other codes contained in the specifications.&#xD;
&#xD;
CPT(R) contained in the Measure specifications is copyright 2004-2014 American Medical Association. LOINC(R) copyright 2004-2014 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT [R]) copyright 2004-2014 International Health Terminology Standards Development Organisation. ICD-10 copyright 2014 World Health Organization. All Rights Reserved.</copyright><disclaimer>These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.&#xD;
&#xD;
THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.&#xD;
&#xD;
Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount/><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>A 10 percent decrease in total cholesterol levels (population wide) may result in an estimated 30 percent reduction in the incidence of coronary heart disease (CHD) (Centers for Disease Control and Prevention 2000). Based on data from the Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults:&#xD;
*Less than half of persons who qualify for any kind of lipid-modifying treatment for CHD risk reduction are receiving it&#xD;
*Less than half of even the highest-risk persons, those who have symptomatic CHD, are receiving lipid-lowering treatment&#xD;
*Only about a third of treated patients are achieving their LDL goal; less than 20 percent of CHD patients are at their LDL goal (National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Pressure 2002)&#xD;
&#xD;
According to data from the Behavioral Risk Factor Surveillance System (BRFSS) from 1991 - 2003, the prevalence of cholesterol screening during the preceding 5 years increased from 67.3 percent in 1991 to 73.1 percent in 2003 (Centers for Disease Control and Prevention 2005).&#xD;
&#xD;
Between 1988-94 and 1999-2002, the age-adjusted mean total serum cholesterol level of adults 20 years of age and  older decreased from 206 mg/dL to 203 mg/dL, and LDL cholesterol levels decreased from 129 mg/dL to 123 mg/dL. The mean level of LDL cholesterol for American adults age 20 and older is 123 mg/dL (Carroll et al. 2005). However, even given this decrease, there is still a significant amount of room for improvement.</rationale><recommendations>Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2002) AND Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines (2004) &#xD;
In high-risk persons, the recommended LDL-C goal is &lt; 100 mg/dL. &#xD;
&#xD;
* An LDL-C goal of &lt; 70 mg/dL is a therapeutic option on the basis of available clinical trial evidence, especially for patients at very high risk. &#xD;
* If LDL-C is &gt; 100 mg/dL, an LDL-lowering drug is indicated simultaneously with lifestyle changes. &#xD;
* If baseline LDL-C is &lt; 100 mg/dL, institution of an LDL-lowering drug to achieve an LDL-C level &#xD;
&lt; 70 mg/dL is a therapeutic option on the basis of available clinical trial evidence. &#xD;
* If a high-risk person has high triglycerides or low HDL-C, consideration can be given to combining a fibrate or nicotinic acid with an LDL-lowering drug. When triglycerides are &gt; 200 mg/dL, non-HDL-C is a secondary target of therapy, with a goal 30 mg/dL higher than the identified LDL-C goal. &#xD;
&#xD;
The U.S. Preventive Services Task Force (USPSTF) strongly recommends screening men aged 35 and older for lipid disorders and recommends screening men aged 20 to 35 for lipid disorders if they are at increased risk for coronary heart disease. The USPSTF also strongly recommends screening women aged 45 and older for lipid disorders if they are at increased risk for coronary heart disease and recommends screening women aged 20 to 45 for lipid disorders if they are at increased risk for coronary heart disease.</recommendations><improvementNotations>Higher score indicates better quality</improvementNotations><references><reference>Centers for Disease Control and Prevention (CDC). 2005. "Trends in cholesterol screening and awareness of high blood cholesterol - United States, 1991-2003." MMWR 54;865-870.</reference><reference>Carroll, M.D., D.A. Lacher, P.D. Sorlie, J.I. Cleeman, D.J. Gordon, M. Wolz, S.M. Grundy, C.L. Johnson. 2005. "Trends in serum lipids and lipoproteins of adults. 1960-2002." JAMA 294:1773-1781.</reference><reference>Centers for Disease Control and Prevention (CDC). 2000. "State-specific cholesterol screening trends - United States, 1991-1999." MMWR 49:750-755.</reference><reference>National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2002. "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report." Circulation 106(25):3143-421. </reference><reference>Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39.</reference><reference>U.S. Preventive Services Task Force. 2008. "Screening for lipid disorders in adults" (June) http://www.uspreventiveservicestaskforce.org/uspstf/uspschol.htm &#xD;
</reference></references><definitions>None</definitions><guidance>Only patients who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) are included in this measure</guidance><transmissionFormat>None</transmissionFormat><initialPopDescription>Patients 18 years of age and older with a visit during the measurement period, and an active diagnosis of ischemic vascular disease (IVD) during the measurement period, or who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period</initialPopDescription><denominatorDescription>Equals Initial Population</denominatorDescription><denominatorExclusionsDescription>Not Applicable</denominatorExclusionsDescription><numeratorDescription>Numerator 1: Patients with a complete lipid profile performed during the measurement period&#xD;
Numerator 2: Patients whose most recent LDL-C level performed during the measurement period is &lt;100 mg/dL</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measurePopulationExclusionsDescription>Not Applicable</measurePopulationExclusionsDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="421d558f-250f-41f6-98c2-a5fa58c310fa">None</qualityMeasureSet>
<finalizedDate value="201506121242-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3f77-75c9-013f-77f65cca0144" name="ONC Administrative Sex"/><elementRef id="40280381-3f77-75c9-013f-77f65cca0145" name="Race"/><elementRef id="40280381-3f77-75c9-013f-77f65cca0146" name="Ethnicity"/><elementRef id="40280381-3f77-75c9-013f-77f65cca0147" name="Payer"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="PCI or CABG 12 mo EBS MP" qdmVariable="false" uuid="0DE8020C-F00A-458E-A402-6861B494F6CE"><relationalOp displayName="&lt;= 12 months Ends Before Start Of" operatorType="Less Than or Equal To" quantity="12" type="EBS" unit="months"><setOp displayName="UNION" type="union"><elementRef displayName="Percutaneous Coronary Interventions : Procedure, Performed" id="40280381-3f77-75c9-013f-77f65cca014b" type="qdm"/><elementRef displayName="Coronary Artery Bypass Graft : Procedure, Performed" id="40280381-3f77-75c9-013f-77f65cca014d" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></relationalOp></subTree><subTree displayName="Age gteq 18" qdmVariable="false" uuid="363AD63C-7BCE-4AC9-8C3C-C43640346544"><functionalOp displayName="Age &gt;= 18 years at" operatorType="Greater Than or Equal To" quantity="18" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></functionalOp></subTree><subTree displayName="Dx AMI SBSO MP" qdmVariable="false" uuid="7E471092-6AE6-483A-BFDE-DD73B37374C7"><relationalOp displayName="&lt;= 12 months Starts Before Start Of" operatorType="Less Than or Equal To" quantity="12" type="SBS" unit="months"><elementRef displayName="Acute Myocardial Infarction : Diagnosis, Active" id="40280381-3f77-75c9-013f-77f65cca014c" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></relationalOp></subTree><subTree displayName="Dx IVD overlaps MP" qdmVariable="false" uuid="6C86C01F-1F68-4463-8D46-EA843F821729"><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Ischemic Vascular Disease : Diagnosis, Active" id="40280381-3f77-75c9-013f-77f65cca014a" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></relationalOp></subTree><subTree displayName="Encounter during MP" qdmVariable="false" uuid="FA69953D-611B-403E-B3EB-DD1E37E9B11D"><relationalOp displayName="During" type="DURING"><setOp displayName="UNION" type="union"><elementRef displayName="Office Visit : Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0154" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0158" type="qdm"/><elementRef displayName="Preventive Care Services - Established Office Visit, 18 and Up : Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0155" type="qdm"/><elementRef displayName="Preventive Care Services-Initial Office Visit, 18 and Up : Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0156" type="qdm"/><elementRef displayName="Home Healthcare Services : Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0159" type="qdm"/><elementRef displayName="Annual Wellness Visit : Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0157" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></relationalOp></subTree><subTree displayName="Total Cholesterol during MP" qdmVariable="false" uuid="BC0CED40-DA23-4E3C-9411-052A62C2B255"><relationalOp displayName="During" type="DURING"><elementRef displayName="Total Cholesterol Laboratory Test : Laboratory Test, Performed" id="ba47df55-6330-488e-bd68-097a9ff4ab20" type="qdm"><attribute attrUUID="733d99bb-8324-4546-8a27-c88394e8689c" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></relationalOp></subTree><subTree displayName="HDL_C during MP" qdmVariable="false" uuid="8A7DAFB6-793F-4045-8FBE-6B00D72448A0"><relationalOp displayName="During" type="DURING"><elementRef displayName="HDL-C Laboratory Test : Laboratory Test, Performed" id="a505f0c7-5ff5-431f-aea8-d5074afe54ef" type="qdm"><attribute attrUUID="88f64ccf-41d3-459d-9256-7e98408b9dd7" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></relationalOp></subTree><subTree displayName="Triglycerides during MP" qdmVariable="false" uuid="00B236FB-1F35-4E1D-9E95-EEC904EF0D04"><relationalOp displayName="During" type="DURING"><elementRef displayName="Triglycerides Laboratory Test : Laboratory Test, Performed" id="b5e19a01-58b9-44c3-ba37-f70ead1a4433" type="qdm"><attribute attrUUID="11717c3a-7090-42c4-9151-a827f61494c5" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></relationalOp></subTree><subTree displayName="LDL_C during MP" qdmVariable="false" uuid="785A4E81-097A-4A8E-91E5-88DBABDD5329"><relationalOp displayName="During" type="DURING"><elementRef displayName="LDL-c : Laboratory Test, Performed" id="9de7553b-383a-470f-a5d3-5712fa8d3632" type="qdm"><attribute attrUUID="29c32f62-dd89-4c2d-9dab-8326d3d2e15b" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></relationalOp></subTree><subTree displayName="Most recent LDL_C" qdmVariable="false" uuid="30595281-F240-40A1-9483-7EC6F88F8E95"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="LDL-c : Laboratory Test, Performed" id="9de7553b-383a-470f-a5d3-5712fa8d3632" type="qdm"/><functionalOp displayName="MOST RECENT" type="MOST RECENT"><relationalOp displayName="During" type="DURING"><elementRef displayName="LDL-c : Laboratory Test, Performed" id="9de7553b-383a-470f-a5d3-5712fa8d3632" type="qdm"><attribute attrUUID="46e32cd5-e99e-4e93-9baf-d6875f744b40" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" type="qdm"/></relationalOp></functionalOp><elementRef displayName="LDL-c : Laboratory Test, Performed" id="9de7553b-383a-470f-a5d3-5712fa8d3632" type="qdm"><attribute attrUUID="e0d3ac08-925c-43ad-a8e2-449bba01cb54" comparisonValue="100" mode="Less Than" name="result" unit="mg/dL"/></elementRef></functionalOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 1" type="initialPopulation" uuid="B2C8C825-2462-4FD0-B08C-FF7776C91617"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age gteq 18" id="363AD63C-7BCE-4AC9-8C3C-C43640346544" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="Dx AMI SBSO MP" id="7E471092-6AE6-483A-BFDE-DD73B37374C7" type="subTree"/><subTreeRef displayName="Dx IVD overlaps MP" id="6C86C01F-1F68-4463-8D46-EA843F821729" type="subTree"/><subTreeRef displayName="PCI or CABG 12 mo EBS MP" id="0DE8020C-F00A-458E-A402-6861B494F6CE" type="subTree"/></logicalOp><subTreeRef displayName="Encounter during MP" id="FA69953D-611B-403E-B3EB-DD1E37E9B11D" type="subTree"/></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="E05BF244-8112-4E53-A4A4-9C486F362394"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Numerator 1" type="numerator" uuid="CEFBD582-FE7B-4B2B-A97E-DC38BA10B7DB"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Total Cholesterol during MP" id="BC0CED40-DA23-4E3C-9411-052A62C2B255" type="subTree"/><subTreeRef displayName="HDL_C during MP" id="8A7DAFB6-793F-4045-8FBE-6B00D72448A0" type="subTree"/><subTreeRef displayName="LDL_C during MP" id="785A4E81-097A-4A8E-91E5-88DBABDD5329" type="subTree"/><subTreeRef displayName="Triglycerides during MP" id="00B236FB-1F35-4E1D-9E95-EEC904EF0D04" type="subTree"/></logicalOp></clause><clause displayName="denominatorExclusions" type="denominatorExclusions" uuid="31e1e47f-21f0-412d-a7b0-ef352ac7c838"><logicalOp displayName="AND" type="and"/></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="0ed61e58-8fe8-4b81-a770-41741e0d350f"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="b6d2eca0-b127-4e01-9bd2-40c30568df13"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="7431cbd3-e1e7-4de0-b1f6-005c7d013a24"/></group><group sequence="2"><clause displayName="Initial Population 1" type="initialPopulation" uuid="732202D0-7475-4491-BA4E-AEF3A6953F15"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age gteq 18" id="363AD63C-7BCE-4AC9-8C3C-C43640346544" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="Dx AMI SBSO MP" id="7E471092-6AE6-483A-BFDE-DD73B37374C7" type="subTree"/><subTreeRef displayName="Dx IVD overlaps MP" id="6C86C01F-1F68-4463-8D46-EA843F821729" type="subTree"/><subTreeRef displayName="PCI or CABG 12 mo EBS MP" id="0DE8020C-F00A-458E-A402-6861B494F6CE" type="subTree"/></logicalOp><subTreeRef displayName="Encounter during MP" id="FA69953D-611B-403E-B3EB-DD1E37E9B11D" type="subTree"/></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="D11CBD66-9923-430C-8229-EA49CA3B9A1C"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Numerator 2" type="numerator" uuid="42C96EEA-274C-41CA-9B62-A9B214E5AC44"><logicalOp displayName="AND" type="and"><comment displayName="comment" type="comment"/><subTreeRef displayName="Most recent LDL_C" id="30595281-F240-40A1-9483-7EC6F88F8E95" type="subTree"/></logicalOp></clause><clause displayName="denominatorExclusions" type="denominatorExclusions" uuid="8b83ab0d-b1bc-4a62-bf60-c0365bb030f2"><logicalOp displayName="AND" type="and"/></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="88268306-6add-427b-81a0-82ac5b521df6"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="208b4952-0bb9-4f0f-835a-36d602431884"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="080c10ce-4360-461a-8291-880e155da077"/></group></measureGrouping><elementLookUp><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3f77-75c9-013f-77f65cca014c" name="Acute Myocardial Infarction" oid="2.16.840.1.113883.3.464.1003.104.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65cca014c" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0157" name="Annual Wellness Visit" oid="2.16.840.1.113883.3.526.3.1240" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65ccb0157" version="1"/><qdm datatype="Patient Characteristic Birthdate" id="cb8d3f9a-37b1-44e8-bc36-7f558de4322f" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="cb8d3f9a-37b1-44e8-bc36-7f558de4322f" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Procedure, Performed" id="40280381-3f77-75c9-013f-77f65cca014d" name="Coronary Artery Bypass Graft" oid="2.16.840.1.113883.3.464.1003.104.12.1002" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65cca014d" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3f77-75c9-013f-77f65cca0146" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3f77-75c9-013f-77f65cca0146" version="1"/><qdm datatype="Patient Characteristic Expired" id="c9a5c244-8826-4fab-998f-a48ad5b0efc4" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="c9a5c244-8826-4fab-998f-a48ad5b0efc4" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0158" name="Face-to-Face Interaction" oid="2.16.840.1.113883.3.464.1003.101.12.1048" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65ccb0158" version="1"/><qdm datatype="Laboratory Test, Performed" id="a505f0c7-5ff5-431f-aea8-d5074afe54ef" name="HDL-C Laboratory Test" oid="2.16.840.1.113883.3.464.1003.104.12.1012" suppDataElement="false" taxonomy="Grouping" uuid="a505f0c7-5ff5-431f-aea8-d5074afe54ef" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0159" name="Home Healthcare Services" oid="2.16.840.1.113883.3.464.1003.101.12.1016" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65ccb0159" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3f77-75c9-013f-77f65cca014a" name="Ischemic Vascular Disease" oid="2.16.840.1.113883.3.464.1003.104.12.1003" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65cca014a" version="1"/><qdm datatype="Laboratory Test, Performed" id="9de7553b-383a-470f-a5d3-5712fa8d3632" name="LDL-c" oid="2.16.840.1.113883.3.117.1.7.1.215" suppDataElement="false" taxonomy="LOINC" uuid="9de7553b-383a-470f-a5d3-5712fa8d3632" version="1.0"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3f77-75c9-013f-77f65cca0149" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3f77-75c9-013f-77f65cca0149" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0154" name="Office Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65ccb0154" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3f77-75c9-013f-77f65cca0144" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3f77-75c9-013f-77f65cca0144" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3f77-75c9-013f-77f65cca0147" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3f77-75c9-013f-77f65cca0147" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Procedure, Performed" id="40280381-3f77-75c9-013f-77f65cca014b" name="Percutaneous Coronary Interventions" oid="2.16.840.1.113883.3.464.1003.104.12.1010" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65cca014b" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0155" name="Preventive Care Services - Established Office Visit, 18 and Up" oid="2.16.840.1.113883.3.464.1003.101.12.1025" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65ccb0155" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3f77-75c9-013f-77f65ccb0156" name="Preventive Care Services-Initial Office Visit, 18 and Up" oid="2.16.840.1.113883.3.464.1003.101.12.1023" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3f77-75c9-013f-77f65ccb0156" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3f77-75c9-013f-77f65cca0145" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3f77-75c9-013f-77f65cca0145" version="1"/><qdm datatype="Laboratory Test, Performed" id="ba47df55-6330-488e-bd68-097a9ff4ab20" name="Total Cholesterol Laboratory Test" oid="2.16.840.1.113883.3.464.1003.104.12.1013" suppDataElement="false" taxonomy="Grouping" uuid="ba47df55-6330-488e-bd68-097a9ff4ab20" version="1.0"/><qdm datatype="Laboratory Test, Performed" id="b5e19a01-58b9-44c3-ba37-f70ead1a4433" name="Triglycerides Laboratory Test" oid="2.16.840.1.113883.3.464.1003.104.12.1014" suppDataElement="false" taxonomy="Grouping" uuid="b5e19a01-58b9-44c3-ba37-f70ead1a4433" version="1.0"/></elementLookUp></measure>